1 August 2023
- Scientists have developed a breakthrough method to detect structural variations on proteins based on nanopore technologies.
- Protein chains are fed through an engineered nanopore, with subtle variations in structure detected through the modulation of tiny electrical currents.
- The method could transform our understanding of how protein variants are associated with diseases, and allow point-of-care diagnostics.
A team of scientists led by the University of Oxford have achieved a significant breakthrough in detecting modifications on protein structures. The method, published in Nature Nanotechnology, employs innovative nanopore technology to identify structural variations at the single-molecule level, even deep within long protein chains.
Human cells contain approximately 20,000 protein-encoding genes. However, the actual number of proteins observed in cells is far greater, with over 1,000,000 different structures known. These variants are generated through a process known as post-translational modification (PTM), which occurs after a protein has been transcribed from DNA. PTM introduces structural changes such as the addition of chemical groups or carbohydrate chains to the individual amino acids that make up proteins. This results in hundreds of possible variations for the same protein chain.
These variants play pivotal roles in biology, by enabling precise regulation of complex biological processes within individual cells. Mapping this variation would uncover a wealth of valuable information that could revolutionise our understanding of cellular functions. But to date, the ability to produce comprehensive protein inventories has remained an elusive goal.
To overcome this, a team led by researchers at the University of Oxford’s Department of Chemistry has successfully developed a method for protein analysis based on nanopore DNA/RNA sequencing technology. In this approach, a directional flow of water captures and unfolds 3D proteins into linear chains that are fed through tiny pores, just wide enough for a single amino acid molecule to pass through. Structural variations are identified by measuring changes in an electrical current applied across the nanopore. Different molecules cause different disruptions in the current, giving them a unique signature.
The team successfully demonstrated the method’s effectiveness in detecting three different PTM modifications (phosphorylation, glutathionylation, and glycosylation) at the single-molecule level for protein chains over 1,200 residues long. These included modifications deep within the protein’s sequence. Importantly, the method does not require the use of labels, enzymes or additional reagents.
According to the research team, the new protein characterisation method could be readily integrated into existing portable nanopore sequencing devices to enable researchers to rapidly build protein inventories of single cells and tissues. This could facilitate point-of-care diagnostics, enabling the personalized detection of specific protein variants associated with diseases including cancer and neurodegenerative disorders.
Professor Yujia Qing (Department of Chemistry, University of Oxford), contributing author for the study, said: ‘This simple yet powerful method opens up numerous possibilities. Initially, it allows for the examination of individual proteins, such as those involved in specific diseases. In the longer term, the method holds the potential to create extended inventories of protein variants within cells, unlocking deeper insights into cellular processes and disease mechanisms.’
Professor Hagan Bayley (Department of Chemistry, University of Oxford), contributing author and co-founder of Oxford Nanopore Technologies, added: ‘The ability to pinpoint and identify post-translational modifications and other protein variations at the single-molecule level holds immense promise for advancing our understanding of cellular functions and molecular interactions. It may also open new avenues for personalised medicine, diagnostics, and therapeutic interventions.’
Oxford Nanopore Technologies, a spinout company launched in 2005 based on Professor Bayley’s research, has become established as a front-runner in next-generation sequencing technologies. Oxford Nanopore’s patented nanopore technology enables scientists to sequence nucleic acids (DNA and RNA) quickly using portable, inexpensive devices – in contrast to standard sequencing, which typically requires dedicated laboratories. Oxford Nanopore devices have revolutionised fundamental and clinical genomics and played a critical role during the COVID-19 pandemic in helping to track the spread of new coronavirus variants.
This work was carried out in collaboration with the research group of mechanobiologist Sergi Garcia-Maynes at King’s College London and the Francis Crick Institute.
Notes to editors:
The research findings have been published in the journal Nature Nanotechnology under the title, ‘Enzyme-less nanopore detection of post-translational modifications within long polypeptides’: https://www.nature.com/articles/s41565-023-01462-8
For media enquiries and interview requests, contact: Professor Yujia Qing, Department of Chemistry, University of Oxford: email@example.com +44 1865 272662
Professor Hagan Bayley, Department of Chemistry, University of Oxford: firstname.lastname@example.org
About the University of Oxford
Oxford University has been placed number 1 in the Times Higher Education World University Rankings for the seventh year running, and number 2 in the QS World Rankings 2022. At the heart of this success are the twin-pillars of our ground-breaking research and innovation and our distinctive educational offer.
Oxford is world-famous for research and teaching excellence and home to some of the most talented people from across the globe. Our work helps the lives of millions, solving real-world problems through a huge network of partnerships and collaborations. The breadth and interdisciplinary nature of our research alongside our personalised approach to teaching sparks imaginative and inventive insights and solutions.
Through its research commercialisation arm, Oxford University Innovation (OUI), Oxford is the highest university patent filer in the UK and is ranked first in the UK for university spinouts, having created more than 300 new companies since 1988. Over a third of these companies have been created in the past five years. Our Incubator at OUI supports the entrepreneurial ambition of University staff, students and alumni, and has created over 50 startups since 2011.
The university is working with partners in Oxford’s innovation ecosystem to harness exceptional science and technology and turn it into commercially successful businesses that drive societal impact, transform lives globally, and fuel economic growth. We are seeing success in engaging more investors and strategic partnerships, developing more space, attracting more talent, and creating more opportunities for entrepreneurs and their companies to scale. We are increasingly connected locally, nationally and globally.
For every £1 million invested in research at the University results in an additional economic output of £5.3 million across the UK economy. For each £1 million of its research income, the University’s research and knowledge exchange activities generated a total of £10.3 million in economic impact across the UK.
The university is a catalyst for prosperity in Oxfordshire and the United Kingdom, contributing £15.7 billion to the UK economy in 2018/19, and supports more than 28,000 full time jobs.
Find out more: https://innovation.ox.ac.uk/